BioSpace News Archive

Fusion Pharmaceuticals Inc. today announced that the compensation committee of the Company’s Board of Directors granted stock option awards to purchase an aggregate of 68,000 shares of its common stock to two employees outside Fusion’s 2020 Stock Option and Incentive Plan.

Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, announced that two abstracts have been accepted for poster presentations at the European Association for the Study of the Liver Congress 2023 taking place June 21 - 24, 2023 in Vienna, Austria.

IRay Technology Co., Ltd., a leading brand in the thermal imaging industry, has shown itself with a high profile at WIN EURASIA 2023 in Istanbul.

CymaBay Therapeutics, Inc. announced it will make three presentations at the European Association for the Study of the Liver ‘s The International Liver Congress™ 2023.

Axol Bioscience Ltd., a leading pluripotent stem cell technology provider for drug discovery has signed an exclusive agreement with StrataStem to access and commercialize its extensive collection of Alzheimer’s Disease patient samples.

RetinalGeniX™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”), announced today the hiring of Owen Watson, MS.

AbTherx, Inc., a privately held biotech company with novel technologies that accelerate antibody discovery, announced the launch of its next-generation human antibody discovery platform.

Labcorp (NYSE: LH), a leading global life sciences company, today announced the appointment of Dr. Paul Rothman to its Board of Directors as an independent member.

Actinium Pharmaceuticals, Inc. announced that it will be added as a member of the small-cap Russell 2000® and all-cap Russell 3000® Indexes as part of the 2023 Russell indexes reconstitution, according to a preliminary list of additions posted May 19 and effective upon the U.S. market close on June 23, 2023.

Enanta Pharmaceuticals, Inc. today announced that preclinical data from Enanta’s out-licensing portfolio has been accepted for a poster presentation at the European Association for the Study of the Liver (EASL) International Liver Congress 2023 being held June 21 – 24, 2023 in Vienna, Austria at the Messe Wien Exhibition Congress Centre.